image
Healthcare - Biotechnology - NASDAQ - US
$ 10.32
-4.27 %
$ 1.17 B
Market Cap
-2.86
P/E
Price Target Average
351.55%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
32.12%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Dyne Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for DYN of $46.6 , with forecasts ranging from a low of $34 to a high of $53 .
DYN Lowest Price Target Wall Street Target
34 USD 229.46%
DYN Average Price Target Wall Street Target
46.6 USD 351.55%
DYN Highest Price Target Wall Street Target
53 USD 413.57%
Price
Max Price Target
Min Price Target
Average Price Target
555550504545404035353030252520201515101055Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart DYN

image
$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart DYN

image
$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart DYN

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)20232023202420242025202520262026202720272028202820292029